Delivery Order SPE2DX15D3306-SPE2DX24FAENG
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ESBRIET 267 MG CAPSULE 270S. The delivery order has a potential value of $3,311.50 and a performance period through February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $3,311.50 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562677205 ESBRIET 267 MG CAPSULE 270S. As the prime contractor, Amerisourcebergen Drug Corp will deliver the specified pharmaceutical product from its Conshohocken, Pennsylvania location with performance to be completed by November 24, 2023. No set-aside designation was applied to this award...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order worth $3,311.50 by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the delivery of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product, with a completion date of March 26, 2024. This delivery order is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $3,311.50 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 4562954016 ESBRIET 267 MG CAPSULE 270S. The delivery order was awarded on November 30, 2023 under the base indefinite delivery contract held by Amerisourcebergen Drug Corp, with performance to be completed by December 21, 2023 at its Conshohocken, Pennsylvania facility. No set aside designation was...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,311.50 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, to be completed by March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00, which serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a firm fixed price of $3,311.50 and a completion date of March 18, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and does not have any major subcontractors listed. The contract was...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ESBRIET 801 MG TABLET 90S. The total potential value of the order is $3,311.50, and the period of performance runs through January 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards to supply pharmaceuticals, medical supplies,...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4564247572 - Esbriet 267 mg capsules. The contract has a ceiling value of $3,311.50 and a performance period through May 2, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will provide these specialty pharmaceutical products to support military treatment programs and facilities. The contract has no set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a for-profit organization and major pharmaceutical distributor. The $3,311.50 firm-fixed-price award is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with an ultimate completion date of August 14, 2024. The contract has no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Department of Defense's Medical Supply Chain (VPDLATSMED-A) to AmerisourceBergen Drug Corp's Corporate Office Division, a subsidiary of AmerisourceBergen Corporation, one of the largest pharmaceutical distribution companies worldwide. The $3,311.50 firm-fixed-price contract is for the delivery of 4564450688 - ESBRIET 801 MG TABLET 90S, with a completion date of May 21, 2024. The award is not associated with a set-aside program. AmerisourceBergen Drug...
- SPE2DX15D3306Indefinite Delivery Contract
- SPE2DX15D3306-SPE2DX24FAENGDelivery Order
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,867,993 ESBRIET 267 MG CAPSULE 270S for a total potential value of $3,311.50. This delivery order has a completion date of March 26, 2024 and was awarded on March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization headquartered in Conshohocken, Pennsylvania. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with a potential value of up to $999,999,999.00 from DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 3/5/24 |